Next Article in Journal
A Novel de Novo Variant in 5′ UTR of the NIPBL Associated with Cornelia de Lange Syndrome
Next Article in Special Issue
Genetic Profile of Patients with Limb-Girdle Muscle Weakness in the Chilean Population
Previous Article in Journal
Association of SNP rs5069 in APOA1 with Benign Breast Diseases in a Mexican Population
Previous Article in Special Issue
Current and Future Approaches to Classify VUSs in LGMD-Related Genes
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Estrogen Receptor Type 1 and Type 2 Presence in Paravertebral Skeletal Muscles: Expression Level and Relation to Phenotype in Children with Idiopathic Scoliosis

by
Tomasz Kotwicki
1,
Marek Tomaszewski
1,
Mirosław Andrusiewicz
2,
Aleksandra Śliwa
2,
Błażej Rusin
1,3 and
Małgorzata Kotwicka
2,*
1
Department of Spine Disorders and Pediatric Orthopedics, Faculty of Medicine, Poznan University of Medical Sciences, 28 Czerwca 1956 r. Street 135/147, 61-545 Poznan, Poland
2
Chair and Department of Cell Biology, Faculty of Health Sciences, Poznan University of Medical Sciences, Rokietnicka 5D, 60-806 Poznan, Poland
3
Halluxmed Surgery of the Foot/Knee, Komornicka 57, 62-052 Komorniki, Poland
*
Author to whom correspondence should be addressed.
Genes 2022, 13(5), 739; https://doi.org/10.3390/genes13050739
Submission received: 18 February 2022 / Revised: 21 April 2022 / Accepted: 21 April 2022 / Published: 22 April 2022
(This article belongs to the Special Issue Genetics of Muscular Disorders)

Abstract

:
The study aimed to detect the presence and assess the expression levels of the estrogen receptors type 1 (ESR1) and type 2 (ESR2) within paravertebral skeletal muscles of female patients with idiopathic scoliosis (IS) in relation to phenotype parameters. Intraoperatively, the muscle samples were obtained from 35 adolescent females. The RT-qPCR, western blot and immunohistochemistry techniques were applied. The ESR1 and ESR2 were detected within paravertebral skeletal muscle cells, either the superficial or the deep ones. The ESR1 expression level was significantly higher in the deep muscles compared to the superficial ones. A left-right asymmetry of the ESR1 and ESR2 expression level was demonstrated in the deep muscles. There was a significant relationship between the expression asymmetry and either the Cobb angle or the progression risk factor: both parameters decreased to the smallest values in the case of symmetric ESR1 or ESR2 expression, while they increased with increasing expression asymmetry. In conclusion, the ESR1 and ESR2 presence was confirmed in skeletal paravertebral muscles of patients with idiopathic scoliosis. The increased expression level and asymmetry of estrogen receptors in deep skeletal muscles was related to increasing scoliotic deformity magnitude or increasing risk of deformity deterioration. These findings may highlight the etiopathogenesis of IS in children.

1. Introduction

Idiopathic scoliosis (IS) is the most frequent developmental deformity of the spine in children and affects 2–3% of the general population [1]. The IS definition formulated by the Scoliosis Research Society (SRS) comprises a lateral curvature of the spine with vertebral axial rotation, presenting the Cobb angle of at least 10°, as measured on the anteroposterior radiograph made in a standing position [1].
A three-dimensional scoliotic deformity manifests with a sagittal plane disorder of the physiological thoracic kyphosis or lumbar lordosis, a lateral inflection in the frontal plane, and axial vertebrae rotation in the horizontal plane. The IS prevalence in females is two times higher in boys when the Cobb angle is 10° to 30°, however, with the angle of more than 30°, the ratio increases to 8:1 in favor of girls who are more prone to scoliosis deterioration during adolescence [1].
So far, the IS pathogenesis has not been explained. There are numerous hypotheses pointing to the origins of the deformity in the genetic [2,3,4], biochemical, and biomechanical, including relative anterior spine overgrowth, neurohormonal, bone, and muscular factors [5]. To keep an upright posture, constant coordination between the central nervous system and the skeletal and muscular systems is required, so dysfunction and/or improper communication between them may result in the IS occurrence [5]. Stokes proposed a vicious circle hypothesis for scoliosis curve progression: continuous asymmetrical loading of the spine beyond a given threshold value triggers curve progression [6].
Researchers have postulated that in the paravertebral muscles, the asymmetric expression of the melatonin receptor 1A/B, calmodulin, and nerve growth factor [7] may be involved in IS pathogenesis. It remains unclear whether the observed asymmetry in the expression of the aforementioned factors represents the primary causative factor or a secondary phenomenon induced by the asymmetry of the forces exerted over the vertebral column.
Estrogen receptor 1 (ESR1) and estrogen receptor 2 (ESR2) were shown to be expressed unevenly in various tissues. Both receptor forms can be present together within the same tissue. However, there exist tissues wherein one receptor presents a higher expression level than the other. Few studies have described the estrogen receptors (ESRs) expression in human skeletal muscle. Lemoine et al. identified ESR1 at the mRNA level in the pectoral and the deltoid muscles [8]. Wiik et al. localized ESR1 in the vastus lateralis muscle, both on mRNA and protein levels [9]. Later on, a similar observation was made for the ESR1 and ESR2 in skeletal muscles, both in male and female patients [10]. Few other studies have investigated the expression of ESR1 and ESR2 in deep paravertebral muscles of IS patients. Kudo et al. described asymmetry of ESR1 expression in the paravertebral muscles [7]. On the other hand, Zamecnik et al. did not confirm the asymmetry of ESR2 expression [11,12].
It is postulated that estrogen affects the strength of skeletal muscle. It was shown in meta-analysis studies that estrogen hormone replacement therapy had a significant effect on muscle force in postmenopausal women. The mechanism for estrogen action in most tissues is mediated through estrogen receptors that appear to modify muscle force at the molecular level [13,14]. Modulation of the estrogen receptors’ action could be determined by their expression level and both epigenetic and genetic alterations. Our previous studies showed that, e.g., differences in methylation levels in estrogen receptor genes may be associated with IS etiopathogenesis and may affect the tissue-dependent response to estrogens [15,16]. Moreover, many promising polymorphisms within different genes (including ESR1, ESR2) have been identified for the occurrence and curve progression of idiopathic scoliosis [17]. The SNPs identified in ESR1 could be associated with, e.g., sarcopenia characterized by loss of muscle mass and strength [18] or protection against muscle injury by lowering muscle stiffness [19]. Little is known about ESR2 genetic alterations concerning skeletal muscle tissue function, which is impaired in idiopathic scoliosis. The ESR1 expression might be related to the muscular load on either side of scoliosis.
Our previous studies focused on the ESR2 gene polymorphism in patients with idiopathic scoliosis [20], as well as on methylation of both ESR1 and ESR2 genes [15,16]. The methylation pattern of CpG sites in the regulatory regions of the ESR2 gene in the deep paraspinal muscle tissue was associated with either the occurrence but not with the severity of IS. The difference in ESR1 T-DMR2 (tissue dependent and differentially methylated region 2) CpGs methylation of the deep paravertebral muscles on the concave side of the curvature may be associated with IS severity. We also investigated the presence of estrogen receptor coactivator proline glutamic acid and leucine-rich protein in deep paravertebral muscles of patients with idiopathic scoliosis [21].
Estrogens influence skeletal muscle activity on several levels. Estrogens regulate vascular-endothelial growth factor production. The factor stimulates angiogenesis, cell differentiation and anti-apoptotic action in muscle cells [22]. They participate in nitric oxide production, modulating muscle repair, and adaptation to physical training [23]. Estrogens regulate oxidative metabolism within skeletal muscle by shifting substrate metabolism and reducing liver and muscle glycogen usage [24].
Analyzes concerning the concentration level of circulating estrogens are inconsistent. A study performed on adult females with IS revealed decreased circulating estradiol levels compared to controls [25]. However, Raczkowski found no difference in estradiol concentrations [26]. In 2015, Kulis et al. stated that in both pre- and post-menarchial scoliotic girls, estradiol levels were lower than pre- and post-menarchial controls [27]. The uncertain data led to the hypothesis that ESR abnormalities (in structure, location, or quantity) could be the reason for inappropriate muscular tissue response to estrogens.
The study aimed to investigate whether ESR1 or/and ESR2 are present in the paravertebral muscles of IS patients at both mRNA and protein levels. Moreover, the relation of the ESRs’ gene expression versus scoliosis radiological parameters was investigated.

2. Materials and Methods

2.1. Patients

Thirty-five Caucasian girls from one Central European country (Poland) underwent surgical scoliosis correction at the Department of Spine Disorders and Pediatric Orthopedics of Poznan University of Medical Science. The inclusion criteria were: diagnosis of IS, indication for surgical scoliosis correction, and informed consent. Out of 35 patients, there were 12 Adolescent Idiopathic Scoliosis (AIS) patients and 23 Early Onset Idiopathic Scoliosis (EOIS) patients. According to the Lenke scoliosis classification, the patients’ mean age was 15 years and 5 months ± 26 months [28]. The patients demonstrated Lenke types as follows, type I: 18 patients, type II: 4, type III: 9, type IV: 1, type VI: 3 patients. The radiological examination was performed using standing AP and lateral long cassette radiographs. The mean Cobb angle value was 74.8° ± 19.1°. The patients underwent radiological and clinical examinations (Table 1).

2.2. Radiological Examination

The available radiographs of the spine, which had been routinely performed during scoliosis therapy, were used. No additional radiograph was prescribed. The entire spine-long cassette standing antero-posterior radiographs were used. One parameter was measured: scoliosis angle in degrees by the Cobb method involving the measurement of the angle between the line plotted along the upper vertebral body of the upper-end vertebra and the lower vertebral body of the lower-end vertebra of the spinal curvature.
One additional parameter was calculated: the scoliosis progression risk factor (PRF) according to the formula proposed by Lonstein and Carlson [29]:
Progression   risk   factor   ( PRF ) = Cobb   angle   3 × Risser   sign calendar   age
The Risser sign was assessed in a regular way from 0 to 5.

2.3. Muscle Tissue Samples

Muscle tissue samples were obtained intraoperatively from the following skeletal muscles: (1) concave deep paravertebral, (2) convex deep paravertebral, (3) superficial; the samples were obtained at the apical level of the primary scoliotic curvature.
Each skeletal muscle sample was split into three fragments: (1) material for RT-qPCR was immersed in RNase inhibitor (RNALater; Sigma; Saint Louis, MO, USA) and stored at −80 °C until mRNA isolation, (2) material for immunohistochemistry was immediately fixed in 4% paraformaldehyde (Chempur; Piekary Śląskie, Poland), and (3) material for protein isolation was placed in phosphate buffered saline (PBS, Chempur; Piekary Ślaskie, Poland) and stored at −80 °C until further procedures.

2.4. Isolation of Total Cellular RNA

Muscle tissue samples (~100 mg) were snap-frozen and homogenized using a mortar and a pestle. The obtained tissue powder was used for total RNA extraction using TriPure Isolation Reagent (Roche; Basel, Switzerland) according to the manufacturer with a modification of RNA precipitation step. The RNA was precipitated with 600 µL of isopropanol at −80 °C for 10 min instead of 500 µL of isopropanol at room temperature. The TriPure isolation protocol was carried out twice for each tissue sample.
The quantity and purity of total RNA were analyzed spectrophotometrically using the NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). The integrity of the RNA was evaluated by denaturing formaldehyde agarose gel electrophoresis in FA buffer (20 mM MOPS, 5 mM sodium acetate, 1 mM EDTA, 200 mM paraformaldehyde; pH 7.0; Sigma-Aldrich; Saint Louis, MO, USA). One microliter of isolated RNA was separated in the presence of ethidium bromide, and gels were visualized with G:BOX imaging system.

2.5. Reverse Transcription and Quantitative mRNA Assessment

The reverse transcription reaction (RT) was conducted using Transcriptor Reverse Transcriptase according to the manufacturer’s protocol (Roche; Basel, Switzerland) in a total volume of 20 µL. One microgram of isolated total RNA with 5 mM oligo(d)T10 primer (Genomed; Warsaw, Poland) in RNase/DNase/pyrogen-free water (Thermo Fisher Scientific, Waltham, MA, USA) was denatured 10 min at 65 °C. Samples were chilled on ice. The reaction mixture was then supplemented with 5 U ribonuclease inhibitor (RNasin, Roche; Basel, Switzerland), 10 U of Transcriptor Reverse Transcriptase (Roche), 10 mM dNTPs (Novayzm; Poznan, Poland) and 1× reaction buffer (Roche; Basel, Switzerland). The thermal profile of cDNA synthesis was as follow: 10 min at 25 °C, 30 minutes at 55 °C, and 5 min at 85 °C. cDNA was stored in −20 °C until further analysis but no longer than seven days.
Subsequently, cDNA was used in a quantitative polymerase chain reaction (qPCR) with LightCycler 2.0 carousel glass capillary-based system (Roche, Manheim, Germany). All reactions were made in duplicates using independently synthesized cDNA.

2.6. Quantitative Polymerase Chain Reaction

Quantitative Polymerase Chain Reaction (qPCR) assays were designed to cover all splice variants of analyzed genes. In the case of ESR1 (GenBank: NM_000125.3; NM_001122740.1; NM_001122741.1; NM_001122742.1) the qPCR was conducted with TaqMan Hydrolysis Probes (Roche; Basel, Switzerland). The probes were selected with ProbeFinder software v. 2.50 (available at https://lifescience.roche.com/shop/en/us/overviews/brand/universal-probe-library; last accessed on 28 September 2017; discontinued). Human ready to use HPRT Reference Gene Assay (assay No 05046157001; Roche; Basel, Switzerland) was used as an internal control and relative expression level assessment.
The final concentration of reagents in assays in the total volume of 20 µL reaction mix was used to quantify as follows: 1× FastStart TaqMan Probe Master Mix (Roche; Manheim, Germany), 5 µL cDNA, 0.5 mM of each primer set (Genomed; Warsaw, Poland) and 0.1 mM GOI hydrolysis probe or 0.4 mM reference gene Probe (Roche; Manheim, Germany).
The ESR2 expression (GeneBank: NM_001437; NM_001040275; NM_001040276) was quantified using SybrGreen I. In this assay, expression of the HPRT reference gene (GenBank NM_000194.2) was measured using the same method. Primers for qPCRs with SybrGreen I were designed using Primer3Plus software v.2.3.6 (http://primer3plus.com, last accessed on 12 January 2012) and verified using BLAST alignment.
In SybrGreen I assays, the reaction mix contained: 1× Light Cycler FastStart DNA Master SybrGreen I (Roche; Basel, Switzerland), 3 mM Mg2+ solution, 3 µL cDNA, 0.5 mM of each primer (Genomed, Warsaw, Poland) in the total volume of 20 µL. After amplification, the identity of the ESR2 and HPRT products was confirmed by melting curves analyses.
Primers and probes used in qPCR are presented in Table 2. The thermal profiles of the reactions are shown in Table 3.
Reaction efficiencies were derived from qPCR reactions performed using decimal dilutions of RT-qPCR products purified with DNA Clean & Concentrator kit (Zymo Research; Irvine, CA, USA). The expression level was normalized against standard curves and HPRT reference gene using LightCycler 4.05 software. The relative expression level of ERSs (concentration ratio) was used for statistical analyses.
Randomly selected ESR2 qPCR products were sequenced to confirm the specificity of amplification. As the HPRT reference gene was amplified in a previously validated SybrGreen assay and with a commercially available HPRT assay, verification of the qPCR product was not required.

2.7. Protein Concentration and Western Blot Analyses

Tissue samples immersed in PBS were used for protein isolation and western blot analyses to confirm the protein presence and identity. After mechanical homogenization, tissue samples were suspended in an isolation buffer containing: 320 mmol/L sucrose, 10 mM/L Tris, 1 mM/L Mg2+, 2 mM/L dithiothreitol, 0.2 mM/L protease inhibitor PMSF; pH 7.5 and centrifuged (10 min, 3000× g, 4 °C). The supernatant was transferred into fresh tubes and again centrifuged (10 min, 3 000× g, 4 °C); supernatant containing purified proteins was used in further analyses. According to the manufacturer’s protocol, protein concentration was assessed according to the Bradford assay using Quick Start Bradford Dye Reagent (Bio-Rad; Hercules, CA, USA). The results were compared to standard decimal dilutions of bovine serum albumin fraction V (Roche; Basel, Switzerland), ranging from 1 mg/mL to 1 µg/mL. The protein analyses of the estrogen receptors were performed using denaturing polyacrylamide gel electrophoresis (SDS-PAGE) followed by immunoblotting as described before [30]. Rabbit polyclonal antibodies against ESR1 (sc-8005, Santa Cruz Biotechnology, Dallas, TX, USA), ESR2 (ab3576, Abcam; Cambridge, UK), and GAPDH (sc-25778, Santa Cruz Biotechnology) were used in the following dilutions: 1:500, 1:250, and 1:1000, respectively. The secondary polyclonal goat anti-rabbit antibody linked with horseradish peroxidase was used in a dilution of 1:2500 in blocking buffer. Immunoreactive bands were visualized on membranes using EZ-ECL (Biological Industries; Beit-Haemek, Israel) according to the manufacturer’s protocol. Bands’ optical density was analyzed with G:BOX imaging system and GeneSys software (Syngene; Cambridge, UK).

2.8. Immunohistochemical Localization of ESR1 and ESR2 Proteins

The analysis was performed on 10 randomly selected patients. Tissue, fixed in 4% paraformaldehyde and embedded in paraffin, was cut into 3 µm tissue sections, placed on the silanized glass slides, dewaxed, and rehydrated. Antigens were retrieved by microwave heating in sodium citrate buffer (10 mM Sodium Citrate, 0.05% Tween 20, pH 6.0, Sigma-Aldrich; Saint Louis, MO, USA).
To block endogenous peroxidase activity, tissue sections were treated with 3% hydrogen peroxide for 10 min at room temperature and subsequently incubated in blocking buffer (100 mM Tris-HCl, 0.9% NaCl, 0.05% Tween-20, 3% BSA; pH 7.5). In the next step, slides were incubated in a humid chamber overnight at 4 °C with primary polyclonal anti-ESR1 and anti-ESR2 (the same as used in the case of western blot analysis) diluted in a ratio of 1:50 in blocking buffer. After incubation, slides were rinsed three times in TBS buffer (50 mM Tris-Cl, pH 7.6; 150 mM NaCl).
The location of ESR1 and ESR2 antigens in analyzed tissue sections was visualized with EnVision™+Dual Link System-HRP (Dako, Glostrup, Denmark) according to the manufacturer’s protocol and analyzed using a light microscope. Results of microscopic observations were digitalized.
Archival endometrial tissue samples with known ESRs expression were used as a positive control in these experiments. Negative control experiments included reactions in which a nonimmune serum replaced primary antibodies.

2.9. Asymmetry of ESRs Gene Expression

In 35 girls with IS, the level of ESRs gene expression was assessed for the deep concave (ESR1cnc, ESR2cnc), and deep convex (ESR1cvx, ESR2cvx) muscles.
The ratio (convex to concave) of gene expression level was calculated for each receptor using the formulas:
r E S R 1 = E S R 1 c v x E S R 1 c n c   r E S R 2 = E S R 2 c v x E S R 2 c n c
The correlation of the rESR1 or rESR2 gene expression level versus the Cobb angle and versus the Progression Risk Factor was studied.

2.10. Statistical Analyses

Data analyses were performed using Statistica 10.0 software (StatSoft Inc., Tulsa, OK, USA). Kolmogorov–Smirnov test was applied to check for data normality and the Fisher test was used for variance heterogeneity analysis. The Friedman test and multiple comparison tests were applied. The Pearson correlation coefficient or the Spearman test was used to assess the correlations. p = 0.05 was considered significant.

3. Results

The Cobb angle of the primary curvature ranged from 50° to 114°, mean 74.8° ± 19.1°. The Progression Risk Factor ranged from 1.6 to 8.5, mean 4.5 ± 2.1. For six patients, the PRF value was below 2.5, which according to Lonstein and Carlson [29], corresponds to an 80–90% risk of scoliosis progression. The remaining patients revealed the PRF value greater than 2.5, corresponding to 100% progression risk.

3.1. ESR1 and ESR2 Protein Presence

We confirmed the ESR1 and ESR2 protein presence and identity by western blot analyses in examined samples (Figure 1). Positive immunohistochemical staining for ESR1 and ESR2 was detected in the nuclei of the back muscle cells in all examined samples. The ESR1 expression was also observed in the muscle cell membrane Figure 2.

3.2. ESR1 and ESR2 mRNA Expression Levels

Concentration ratio data (referring to relative expression level) of the ESR1 and ESR2 is presented in Table 4. The obtained values are standard curves PCR efficiency assessment derivates and the normalization of hypoxanthine-guanine phosphoribosyltransferase reference gene (HPRT).
The ESR1 expression levels differed significantly (p = 0.002, Friedman test) among the three muscle groups tested. The ESR1 expression level was significantly lower in superficial muscles compared to deep concave muscles (p < 0.05, multiple comparison test) and compared to deep convex muscles (p < 0.01). The concave versus convex ESR1 expression difference was not significant (p > 0.05). The ESR2 expression level did not differ significantly among the muscle groups (p > 0.05, Friedman test).

3.3. ESR1 Expression Asymmetry

The convex to concave expression ratio was superior to 1.0 in 18 patients (rESR1 > 1), which denoted higher ESR1 expression on the convex side. In comparison, it was inferior to 1.0 in the remaining 17 patients (rESR1 < 1), which denoted higher ESR1 expression on the concave side.

3.4. ESR2 Expression Asymmetry

The convex to concave expression ratio was superior to 1.0 in 14 patients (rESR2 > 1), inferior to 1.0 in 14 patients (rESR2 < 1) and equal to 1.0 in 5 patients (rESR2 = 1).

3.5. ESR1 Expression Level versus Phenotype Parameters

No significant correlation between the ESR1 expression level and the Cobb angle values was found for all patients (N = 35), concerning the superficial muscles (p = 0.1), the deep concave (p = 0.5), nor the deep convex muscles (p = 0.7). However, once the patients were divided into subgroups presenting rESR1 > 1 (N = 18) and showing rESR1 < 1 (N = 17), the correlations revealed significance within these subgroups: a positive linear correlation r = 0.62, p = 0.0097, and a negative linear correlation r = −0.59, p = 0.0251, respectively (Figure 3A,B).
There was no significant correlation between the ESR1 expression level and the Progression Risk Factor (PRF). However, once the patients were divided as described above (rESR1 > 1 and rESR1 < 1), the subgroup analysis revealed a significant correlation: r = 0.59, p = 0.02 and r =−0.69, p = 0.008, respectively (Figure 3C,D).

3.6. ESR2 Expression Level versus Phenotype Parameters

No significant correlation between the ESR2 expression level and the Cobb angle was found for all patients (N = 33) concerning the superficial muscles (p = 0.11), the deep concave (p = 0.86), or the deep convex muscles (p = 0.22). However, once the patients were divided into subgroup presenting rESR2 > 1 (N = 20) and showing rESR2 < 1 (N = 13), the subgroup analysis revealed a significant correlation in the first subgroup (rESR2 > 1): r = 0.73, p = 0.004 and no significant correlation in the second subgroup (rESR2 < 1): r = −0.36, p = 0.27.
No significant correlation between the ESR2 expression level and the Progression Risk Factor was found, p = 0.2. However, once the patients were divided as described above (rESR2 > 1, N = 20 and rESR2 < 1, N = 13), the subgroup analysis revealed a significant correlation in the first subgroup: r = 0.47, p = 0.041 and no significant correlation in the second subgroup (rESR2 < 1): r = −0.48, p = 0.11.

4. Discussion

Using the reverse transcription followed by polymerase chain reaction, the western blot, and immunohistochemistry techniques, the estrogen receptors ESR1 and ESR2 presence were confirmed in the muscular cells of the paraspinal skeletal muscles in a cohort of children with idiopathic scoliosis. Our findings confirm the observations already published by other authors. So far, the published studies on the topic have been carried out in smaller groups: 7 patients for the Lemoine et al. [8] study, 6 patients for the Wiik et al. [9,10] studies, 14 patients for the Kudo et al. study [7], or 18 scoliotic patients for the Zamecnik et al. studies [11,12]. The current study, to the best authors’ knowledge, presents the largest published sample.
Positive immunohistochemical staining for ESR1 and ESR2 proteins was observed in the paraspinal muscle cells nuclei. The ESR1 expression was also observed in the muscle cell membrane indicating the presence of membrane-associated G-protein, sometimes referred to as a so-called third estrogen receptor (GPR30), associated with the non-genomic estrogen receptors’ action [31].
The RT-qPCR technique allowed quantifying the mRNA estrogen receptors expression level in paravertebral muscles of female adolescent patients (N = 35), surgically treated for idiopathic scoliosis. This study showed significantly higher levels of ESR1 expression in deep paravertebral muscles than in superficial ones. No such difference was identified for ESR2. Interestingly, the deep paravertebral muscles present the main muscle body around the spine responsible for both mobility and stability of the vertebral column. They are suspected to be involved in the mechanism of scoliosis occurrence or progression [5]. On the other hand, the back superficial muscles, even if originating from the tips of the spinous processes, belong to the shoulder girdle muscles.
In 2003, Wiik et al. reported the ESR1 expression level to be 180 times higher than the ESR2 level in the vastus lateralis muscle [9]. In our study, the ESR1 to the ESR2 difference was not as important as reported for the vastus lateralis muscle.
The asymmetry of expression of genes responsible for various relevant ligands or receptors was previously reported for the deep paravertebral muscles of patients with idiopathic scoliosis. Acaroglu et al. examined the paravertebral muscles of 18 girls and two boys; they reported a significantly higher calmodulin expression level on the convex than the concave side, while melatonin expression level was found to be similar on both sides of the curvature [32]. On the other hand, Qiu et al. examined 17 girls and three boys; they found higher melatonin receptor type 2 expression levels on the concave compared to the convex side [33]. Kudo et al. stated that the ESR1 mRNA expression on the convex side was higher than on the concave side in the patients with IS, while the expression ratio of NGF and ESR1 in the AIS group was higher than that of control subjects [7]. In turn, Zamecnik et al. do not support the difference in the ESR2 expression level in the paravertebral muscles in patients with scoliosis compared with the control group without scoliosis [11].
The rationale for introducing the ratio parameter (convex to concave expression ratio) is that this ratio enables the detection of asymmetry of estrogen receptors expression within the skeletal paraspinal muscles. In the case of perfect symmetry of expression, the value of the ratio (convex to concave) is equal to 1.0. In the case of a higher convex expression, the ratio value is superior to 1.0 (r > 1.0), while in the case of a higher concave expression, the ratio value is inferior to 1.0 (r < 1.0). As the estrogen receptors are involved in skeletal muscle function, one can hypothesize that the skeletal muscle function around the apical area of scoliosis could be assessed with this analysis. In the past, the asymmetrical activity of skeletal paraspinal muscles was evoked as the factor related to scoliosis onset or to scoliosis progression in the frame of the “muscular” theory of idiopathic scoliosis etiopathogenesis. Our findings seem to support such a hypothesis. In this study, both the Cobb angle and the Progression Risk Factor expressed the highest values (more severe scoliosis deformity or more progressive scoliosis) when the ratio was clearly superior or clearly inferior to 1.0 (Figure 4).
The observed asymmetry of ESR1 expression might result from mechanical loads applied to the muscles located on either side of the spinal curvature in mechano-transduction. This phenomenon may occur in muscle cells and consists of the conversion of mechanical energy into chemical signals that can cause modification of the expression of certain genes, including the ESR1 gene [6,15]. In 2013, Kim et al. [34] described a spatial model of the musculoskeletal system, which consisted of a simplified trunk model, lumbar spine, pelvis, and muscles combined with an optimization technique to calculate muscle forces in upright and isometric forward flexed posture. The researchers stated that when the muscles are properly activated, they maintain posture and stabilize the lumbar spine.
We report a correlation between the Cobb angle value or the PRF coefficient value against the degree of asymmetry of the ESR1 expression level. Analysis of the relationship between phenotype-related parameters, namely the Cobb angle or the coefficient of progression (PRF) versus the asymmetry of ESR1 expression levels showed that with increasing Cobb angle or increasing PRF value, the asymmetry between the level of ESR1 expression on the convex side versus the concave side increased. The detected correlations were statistically significant and arranged in a specific way, as illustrated in Figure 4. The lowest values of the Cobb angle or the PRF were found for the ESR1 ratio = 1, corresponding to symmetrical ESR1 expression.
The asymmetry of ESR1 expression might be related to the asymmetry of muscular load on either side of scoliosis. These observations may expand our knowledge about the ESR1 and ESR2 expression in paravertebral muscles and the muscles’ role in the pathomechanism of scoliosis. The current state of knowledge does not allow to settle whether the muscles changes are primary or secondary to developing spine deformity.

5. Conclusions

Two types of estrogen receptors are present in the deep paravertebral muscles of patients with idiopathic scoliosis. Their expression was found to be asymmetrical around the apex of the principal scoliosis curvature. The expression asymmetry was revealed to be related to the magnitude of the scoliotic deformity as well as to scoliotic deformity progression. These findings may contribute to understanding the etiopathogenesis of IS in children.

Author Contributions

Conceptualization, T.K. and M.K.; methodology, T.K., M.T., M.A., A.Ś. and B.R., M.K.; formal analysis, T.K. and M.K.; investigation T.K., M.T., M.A., A.Ś., B.R. and M.K.; resources, T.K., M.K. and B.R.; data curation, M.T., M.A., A.Ś., B.R. and M.K.; writing—original draft preparation, T.K., M.T., M.A., A.Ś. and M.K.; writing—review and editing, T.K., M.T., M.A. and M.K.; visualization, T.K., M.T., M.A., A.Ś. and M.K.; supervision, T.K. and M.K.; project administration, Poznan University of Medical Sciences; funding acquisition, T.K., B.R. and M.K. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Science Centre, grant number N N403 583638 and the APC was funded by Poznan University of Medical Sciences.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board of Poznan University of Medical Sciences (protocol code No 875/09 date of approval 5 March 2009).

Informed Consent Statement

Informed consent was obtained from all patients’ parents/legal guardians in the case of underage participants.

Data Availability Statement

The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

  1. Weinstein, S.L.; Dolan, L.A.; Cheng, J.C.; Danielsson, A.; Morcuende, J.A. Adolescent idiopathic scoliosis. Lancet 2008, 371, 1527–1537. [Google Scholar] [CrossRef] [Green Version]
  2. Gurnett, C.A.; Alaee, F.; Bowcock, A.; Kruse, L.; Lenke, L.G.; Bridwell, K.H.; Kuklo, T.; Luhmann, S.J.; Dobbs, M.B. Genetic Linkage Localizes an Adolescent Idiopathic Scoliosis and Pectus Excavatum Gene to the 18q Chromosome. Spine 2009, 34, E94. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Chan, V.; Fong, G.C.Y.; Luk, K.D.K.; Yip, B.; Lee, M.K.; Wong, M.S.; Lu, D.D.S.; Chan, T.K. A genetic locus for adolescent idiopathic scoliosis linked to chromosome 19p13.3. Am. J. Hum. Genet. 2002, 71, 401–406. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Gao, X.; Gordon, D.; Zhang, D.; Browne, R.; Helms, C.; Gillum, J.; Weber, S.; Devroy, S.; Swaney, S.; Dobbs, M.; et al. CHD7 Gene Polymorphisms Are Associated with Susceptibility to Idiopathic Scoliosis. Am. J. Hum. Genet. 2007, 80, 957–965. [Google Scholar] [CrossRef] [Green Version]
  5. Burwell, R.G.; Dangerfield, P.H.; Moulton, A.; Grivas, T.B.; Cheng, J.C.Y. Whither the etiopathogenesis (and scoliogeny) of adolescent idiopathic scoliosis? Incorporating presentations on scoliogeny at the 2012 IRSSD and SRS meetings. Scoliosis 2013, 8, 4. [Google Scholar] [CrossRef] [Green Version]
  6. Stokes, I.A.F.; Burwell, R.G.; Dangerfield, P.H. Biomechanical spinal growth modulation and progressive adolescent scoliosis—A test of the “vicious cycle” pathogenetic hypothesis: Summary of an electronic focus group debate of the IBSE. Scoliosis 2006, 1, 16. [Google Scholar] [CrossRef]
  7. Kudo, D.; Miyakoshi, N.; Hongo, M.; Matsumoto-Miyai, K.; Kasukawa, Y.; Misawa, A.; Ishikawa, Y.; Shimada, Y. Nerve Growth Factor and Estrogen Receptor mRNA Expression in Paravertebral Muscles of Patients With Adolescent Idiopathic Scoliosis: A Preliminary Study. Spine Deform. 2015, 3, 122–127. [Google Scholar] [CrossRef]
  8. Lemoine, S.; Granier, P.; Tiffoche, C.; Rannou-Bekono, F.; Thieulant, M.-L.; Delamarche, P. Estrogen Receptor α mRNA in Human Skeletal Muscles. Med. Sci. Sport. Exerc. 2003, 35, 439–443. [Google Scholar] [CrossRef] [Green Version]
  9. Wiik, A.; Glenmark, B.; Ekman, M.; Esbjornsson-Liljedahl, M.; Johansson, O.; Bodin, K.; Enmark, E.; Jansson, E. Oestrogen receptor β is expressed in adult human skeletal muscle both at the mRNA and protein level. Acta Physiol. Scand. 2003, 179, 381–387. [Google Scholar] [CrossRef]
  10. Wiik, A.; Ekman, M.; Johansson, O.; Jansson, E.; Esbjörnsson, M. Expression of both oestrogen receptor α and β in human skeletal muscle tissue. Histochem. Cell Biol. 2009, 131, 181–189. [Google Scholar] [CrossRef]
  11. Zamecnik, J.; Krskova, L.; Dahmen, R.A.; Hacek, J.; Stetkarova, I.; Vasko, P.; Bocek, V.; Brabec, K.; Krbec, M. Deep paraspinal muscles in idiopathic scoliosis—Expression of calmodulin, melatonin receptor-1a and estrogen receptor-2. J. Neurol. Sci. 2015, 357, e348. [Google Scholar] [CrossRef]
  12. Zamecnik, J.; Krskova, L.; Hacek, J.; Stetkarova, I.; Krbec, M. Etiopathogenesis of adolescent idiopathic scoliosis: Expression of melatonin receptors 1A/1B, calmodulin and estrogen receptor 2 in deep paravertebral muscles revisited. Mol. Med. Rep. 2016, 14, 5719–5724. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Collins, B.C.; Mader, T.L.; Cabelka, C.A.; Iñigo, M.R.; Spangenburg, E.E.; Lowe, D.A. Deletion of estrogen receptor α in skeletal muscle results in impaired contractility in female mice. J. Appl. Physiol. 2018, 124, 980–992. [Google Scholar] [CrossRef] [PubMed]
  14. Baltgalvis, K.A.; Greising, S.M.; Warren, G.L.; Lowe, D.A. Estrogen Regulates Estrogen Receptors and Antioxidant Gene Expression in Mouse Skeletal Muscle. PLoS ONE 2010, 5, e10164. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Janusz, P.; Chmielewska, M.; Andrusiewicz, M.; Kotwicka, M.; Kotwicki, T. Methylation of Estrogen Receptor 1 Gene in the Paraspinal Muscles of Girls with Idiopathic Scoliosis and Its Association with Disease Severity. Genes 2021, 12, 790. [Google Scholar] [CrossRef]
  16. Chmielewska, M.; Janusz, P.; Andrusiewicz, M.; Kotwicki, T.; Kotwicka, M. Methylation of estrogen receptor 2 (ESR2) in deep paravertebral muscles and its association with idiopathic scoliosis. Sci. Rep. 2020, 10, 22331. [Google Scholar] [CrossRef]
  17. Wang, W.; Chen, T.; Liu, Y.; Wang, S.; Yang, N.; Luo, M. Predictive value of single-nucleotide polymorphisms in curve progression of adolescent idiopathic scoliosis. Eur. Spine J. 2022, 1, 1–15. [Google Scholar] [CrossRef]
  18. Khanal, P.; He, L.; Stebbings, G.; Onambele-Pearson, G.L.; Degens, H.; Williams, A.; Thomis, M.; Morse, C.I. Prevalence and association of single nucleotide polymorphisms with sarcopenia in older women depends on definition. Sci. Rep. 2020, 10, 2913. [Google Scholar] [CrossRef] [Green Version]
  19. Kumagai, H.; Miyamoto-Mikami, E.; Hirata, K.; Kikuchi, N.; Kamiya, N.; Hoshikawa, S.; Zempo, H.; Naito, H.; Miyamoto, N.; Fuku, N. ESR1 rs2234693 Polymorphism Is Associated with Muscle Injury and Muscle Stiffness. Med. Sci. Sports Exerc. 2019, 51, 19. [Google Scholar] [CrossRef]
  20. Kotwicki, T.; Janusz, P.; Andrusiewicz, M.; Chmielewska, M.; Kotwicka, M. Estrogen receptor 2 gene polymorphism in idiopathic scoliosis. Spine 2014, 39, E1599–E1607. [Google Scholar] [CrossRef]
  21. Skibinska, I.; Tomaszewski, M.; Andrusiewicz, M.; Urbaniak, P.; Czarnecka-Klos, R.; Shadi, M.; Kotwicki, T.; Kotwicka, M. Expression of Estrogen Receptor Coactivator Proline-, Glutamic Acid- and Leucine-Rich Protein 1 within Paraspinal Muscles in Adolescents with Idiopathic Scoliosis. PLoS ONE 2016, 11, e0152286. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Leboeuf, D.; Letellier, K.; Alos, N.; Edery, P.; Moldovan, F. Do estrogens impact adolescent idiopathic scoliosis? Trends Endocrinol. Metab. 2009, 20, 147–152. [Google Scholar] [CrossRef] [PubMed]
  23. Steensberg, A.; Keller, C.; Hillig, T.; Frosig, C.; Wojtaszewski, J.F.P.; Pedersen, B.K.; Pilegaard, H.; Sander, M. Nitric oxide production is a proximal signaling event controlling exercise-induced mRNA expression in human skeletal muscle. FASEB J. 2007, 21, 2683–2694. [Google Scholar] [CrossRef] [PubMed]
  24. Olde, B.; Leeb-Lundberg, L.M.F. GPR30/GPER1: Searching for a role in estrogen physiology. Trends Endocrinol. Metab. 2009, 20, 409–416. [Google Scholar] [CrossRef]
  25. Phillips, S. Hormonal influences on muscle force: Evidence for an inotropic effect of oestrogen. Sport. Exerc. Inj. 1995, 1, 58–63. [Google Scholar]
  26. Raczkowski, J.W. The concentrations of testosterone and estradiol in girls with adolescent idiopathic scoliosis. Neuro Endocrinol. Lett. 2007, 28, 302–304. [Google Scholar]
  27. Kulis, A.; Goździalska, A.; Drąg, J.; Jaśkiewicz, J.; Knapik-Czajka, M.; Lipik, E.; Zarzycki, D. Participation of sex hormones in multifactorial pathogenesis of adolescent idiopathic scoliosis. Int. Orthop. 2015, 39, 1227–1236. [Google Scholar] [CrossRef]
  28. Lenke, L.G. The Lenke classification system of operative adolescent idiopathic scoliosis. Neurosurg. Clin. N. Am. 2007, 18, 199–206. [Google Scholar] [CrossRef]
  29. Lonstein, J.E.; Carlson, J.M. The prediction of curve progression in untreated idiopathic scoliosis during growth. J. Bone Jt. Surg. Am. 1984, 66, 1061–1071. [Google Scholar] [CrossRef] [Green Version]
  30. Englert-Golon, M.; Andrusiewicz, M.; Żbikowska, A.; Chmielewska, M.; Sajdak, S.; Kotwicka, M. Altered Expression of ESR1, ESR2, PELP1 and c-SRC Genes Is Associated with Ovarian Cancer Manifestation. Int. J. Mol. Sci. 2021, 22, 6216. [Google Scholar] [CrossRef]
  31. Wei, A.; Shen, B.; Williams, L.A.; Bhargav, D.; Yan, F.; Chong, B.H.; Diwan, A.D. Expression and functional roles of estrogen receptor GPR30 in human intervertebral disc. J. Steroid Biochem. Mol. Biol. 2016, 158, 46–55. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Acaroglu, E.; Akel, I.; Alanay, A.; Yazici, M.; Marcucio, R. Comparison of the melatonin and calmodulin in paravertebral muscle and platelets of patients with or without adolescent idiopathic scoliosis. Spine 2009, 34, E659–E663. [Google Scholar] [CrossRef] [PubMed]
  33. Qiu, Y.; Wu, L.; Wang, B.; Yu, Y.; Zhu, Z. Asymmetric expression of melatonin receptor mRNA in bilateral paravertebral muscles in adolescent idiopathic scoliosis. Spine 2007, 32, 667–672. [Google Scholar] [CrossRef] [PubMed]
  34. Kim, Y.E.; Choi, H.W. Paraspinal muscle activation in accordance with mechanoreceptors in the intervertebral discs. Proc. Inst. Mech. Eng. H 2013, 227, 138–147. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Representative western blot analysis showing the presence of ESR1 (A) and ESR2 (B) proteins.
Figure 1. Representative western blot analysis showing the presence of ESR1 (A) and ESR2 (B) proteins.
Genes 13 00739 g001
Figure 2. Immunohistochemical examination of the muscle tissue of individual patient. (AD) and controls (E,F). Hematoxylin and eosin staining ((A)—cross-section, (B)—longitudinal-section; skeletal muscles were identified by peripheral nuclei and large amounts of cytoplasm). Immunolocalization of the ESR1 (C) and ESR2 (D) presence (purple color). ESR1 and ESR2 were detected in the nuclei of the back muscle cells (red arrows); ESR1 expression was also observed in the muscle cell membrane (white arrowhead). Endometrial control tissue–positive control (E), and muscle tissue–negative control (F). In the negative control, the primary antibody was omitted. Scale bar = 100 μm.
Figure 2. Immunohistochemical examination of the muscle tissue of individual patient. (AD) and controls (E,F). Hematoxylin and eosin staining ((A)—cross-section, (B)—longitudinal-section; skeletal muscles were identified by peripheral nuclei and large amounts of cytoplasm). Immunolocalization of the ESR1 (C) and ESR2 (D) presence (purple color). ESR1 and ESR2 were detected in the nuclei of the back muscle cells (red arrows); ESR1 expression was also observed in the muscle cell membrane (white arrowhead). Endometrial control tissue–positive control (E), and muscle tissue–negative control (F). In the negative control, the primary antibody was omitted. Scale bar = 100 μm.
Genes 13 00739 g002
Figure 3. Correlation between ratio (convex to concave) of ESR1 gene expression level (rESR1) in deep paravertebral and phenotype parameters. (A). Correlation between the rESR1 and the value of the Cobb angle in patients with rESR1 < 1. (B). Correlation between the rESR1 and the value of the Cobb angle in patients with rESR1 > 1. (C). Correlation between the rESR1 and the value of the risk of progression factor (PRF) in patients with rESR1 < 1. (D). Correlation between the rESR1 and the value of the PRF in patients with rESR1 > 1. Linear fit lines and 95% confidence intervals are shown in blue.
Figure 3. Correlation between ratio (convex to concave) of ESR1 gene expression level (rESR1) in deep paravertebral and phenotype parameters. (A). Correlation between the rESR1 and the value of the Cobb angle in patients with rESR1 < 1. (B). Correlation between the rESR1 and the value of the Cobb angle in patients with rESR1 > 1. (C). Correlation between the rESR1 and the value of the risk of progression factor (PRF) in patients with rESR1 < 1. (D). Correlation between the rESR1 and the value of the PRF in patients with rESR1 > 1. Linear fit lines and 95% confidence intervals are shown in blue.
Genes 13 00739 g003
Figure 4. Relationship between the ESR1 expression asymmetry (rESR1) and two phenotype parameters: the scoliosis angle (Cobb angle) or the Progression Risk Factor (PRF). The two phenotype parameters, denoting the scoliosis magnitude and the scoliosis deterioration risk, respectively, revealed minimal values in patients presenting symmetry of ESR1 expression (rESR1 of about 1).
Figure 4. Relationship between the ESR1 expression asymmetry (rESR1) and two phenotype parameters: the scoliosis angle (Cobb angle) or the Progression Risk Factor (PRF). The two phenotype parameters, denoting the scoliosis magnitude and the scoliosis deterioration risk, respectively, revealed minimal values in patients presenting symmetry of ESR1 expression (rESR1 of about 1).
Genes 13 00739 g004
Table 1. Selected parameters measured in the patients.
Table 1. Selected parameters measured in the patients.
ParameterValues
Age of surgery
mean ± SD (range)
15 years 5 months ± 26 months (12–21 years; 142–254 months)
Height
mean ± SD (range)
160.1 ± 7.1(147–176 cm)
C7 plumbline7 left7 neutral19 right
Angle of trunk rotation
mean ± SD (range)
17.9 ± 5.7 (5–30 degrees)
Cobb angle
mean ± SD (range)
74.8 ± 19.1 (50–114 degrees)
Apical vertebra level3.3%
Th7 or above
76.7%
Th8 or Th9
20%
Th10 or below
Risser sign
%
0 or 1 or 2
15%
Risser 3
18%
Risser 4
55%
Risser 5
12%
Legend: SD-standard deviation.
Table 2. Primers and probes used in qPCR.
Table 2. Primers and probes used in qPCR.
Primer NamePrimer SequenceProbe
ESR1 forward primer 5′-AATGCTACGAAGTGGGAATGAT-3′probe #67 (Roche Cat. No. 04688660001).
ESR1 reverse primer5′-CAAAGGTTGGCAGCTCTCAT-3′
ESR2 forward primer 5′-GAAGCATTCAAGGACATAATG-3′N/A
ESR2 reverse primer5′-TCCCACTTCGTAACACTTC-3’
HPRT forward primer5′-TGAAGAGCTATTGTAATGACCAGTC-3′N/A
HPRT reverse primer5′-CAAATCCAACAAAGTCTGGC-3′
Legend: N/A-not applicable.
Table 3. Thermal profile for genes quantification.
Table 3. Thermal profile for genes quantification.
CyclesAnalysis ModeUPL Probes
ESR1 and HPRT
SybrGreen I
ESR2HPRT
1Pre-Incubation95 °C, 10 min
45amplification and quantificationdenaturation95 °C, 10 s
annealing60 °C, 30 s55 °C, 5 s54 °C, 5 s
elongation72 °C, 11 s72 °C, 9 s
fluorescence data acquisition72 °C, 1 sat the end of the elongation step
1melting curvedenaturationnone95 °C, 0 s
annealing65 °C, 5 s
denaturation with continuous fluorescence data acquisition95 °C, rampling 0.1 °C/s
1cooling40 °C, 30 s
Legend: UPL-universal ProbeLibrary; HPRT-hypoxanthine-guanine phosphoribosyltransferase reference gene; ESR1-estrogen receptors type 1 gene; ESR2-estrogen receptors type 2 gene.
Table 4. ESR1 and ESR2 expression levels in superficial and deep back muscles in 35 cases.
Table 4. ESR1 and ESR2 expression levels in superficial and deep back muscles in 35 cases.
Muscle GroupMinimumMaximumMeanSD
ESR1
superficial48.0 × 10−667.2 × 10−524.4 × 10−515.1 × 10−5
deep concave97.0 × 10−611.5 × 10−441.3 × 10−528.4 × 10−5
deep convex82.0 × 10−630.0 × 10−448.2 × 10−552.9 × 10−5
ESR2
superficial21.0 × 10−680.0 × 10−316.7 × 10−335.91 × 10−3
deep concave12.1 × 10−414.0 × 10−220.72 × 10−327.27 × 10−3
deep convex94.6 × 10−550.0 × 10−315.57 × 10−312.63 × 10−3
Legend: SD-standard deviation.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Kotwicki, T.; Tomaszewski, M.; Andrusiewicz, M.; Śliwa, A.; Rusin, B.; Kotwicka, M. Estrogen Receptor Type 1 and Type 2 Presence in Paravertebral Skeletal Muscles: Expression Level and Relation to Phenotype in Children with Idiopathic Scoliosis. Genes 2022, 13, 739. https://doi.org/10.3390/genes13050739

AMA Style

Kotwicki T, Tomaszewski M, Andrusiewicz M, Śliwa A, Rusin B, Kotwicka M. Estrogen Receptor Type 1 and Type 2 Presence in Paravertebral Skeletal Muscles: Expression Level and Relation to Phenotype in Children with Idiopathic Scoliosis. Genes. 2022; 13(5):739. https://doi.org/10.3390/genes13050739

Chicago/Turabian Style

Kotwicki, Tomasz, Marek Tomaszewski, Mirosław Andrusiewicz, Aleksandra Śliwa, Błażej Rusin, and Małgorzata Kotwicka. 2022. "Estrogen Receptor Type 1 and Type 2 Presence in Paravertebral Skeletal Muscles: Expression Level and Relation to Phenotype in Children with Idiopathic Scoliosis" Genes 13, no. 5: 739. https://doi.org/10.3390/genes13050739

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop